+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Mycobacterium Tuberculosis Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5230863
  • Report
  • December 2020
  • Region: Global
  • 45 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Aldatu Biosciences Inc
  • Cardiff Oncology Inc
  • Nagasaki University
  • Omniome Inc
  • Qiagen NV
  • Seegene Inc
  • MORE
Summary

The publisher's Medical Devices sector report, “Mycobacterium Tuberculosis Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Mycobacterium Tuberculosis Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Mycobacterial infections diagnosis depends upon smear positivity in sputum samples, culture and chest radiography. For rapid diagnosis, nucleic acid amplification tests such as polymerase chain reaction (PCR), immune-based assays such as enzyme-linked immunosorbent assay (ELISA), skin patch test and rapid culture systems are performed.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Mycobacterium Tuberculosis Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Mycobacterium Tuberculosis Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Mycobacterium Tuberculosis Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aldatu Biosciences Inc
  • Cardiff Oncology Inc
  • Nagasaki University
  • Omniome Inc
  • Qiagen NV
  • Seegene Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Mycobacterium Tuberculosis Tests Overview

3 Products under Development
3.1 Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
3.2 Mycobacterium Tuberculosis Tests - Pipeline Products by Segment
3.3 Mycobacterium Tuberculosis Tests - Pipeline Products by Territory
3.4 Mycobacterium Tuberculosis Tests - Pipeline Products by Regulatory Path
3.5 Mycobacterium Tuberculosis Tests - Pipeline Products by Estimated Approval Date

4 Mycobacterium Tuberculosis Tests - Pipeline Products under Development by Companies
4.1 Mycobacterium Tuberculosis Tests Companies - Pipeline Products by Stage of Development
4.2 Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development

5 Mycobacterium Tuberculosis Tests Companies and Product Overview
5.1 Albert Einstein College of Medicine Company Overview
5.1.1 Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aldatu Biosciences Inc Company Overview
5.2.1 Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Burnet Institute Company Overview
5.3.1 Burnet Institute Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardiff Oncology Inc Company Overview
5.4.1 Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Chronus Pharmaceuticals Inc Company Overview
5.5.1 Chronus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Diagnorite Innovative Healthcare Pvt Ltd Company Overview
5.6.1 Diagnorite Innovative Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 Emory University Company Overview
5.7.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Nagasaki University Company Overview
5.8.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview
5.9 Nipro Corp Company Overview
5.9.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Omniome Inc Company Overview
5.10.1 Omniome Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 OPKO Health Inc Company Overview
5.11.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Pulmonescence Diagnostics Inc Company Overview
5.12.1 Pulmonescence Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Qiagen NV Company Overview
5.13.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
5.14 Rapid Diagnostic Pvt Ltd Company Overview
5.14.1 Rapid Diagnostic Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Rutgers The State University of New Jersey Company Overview
5.15.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview
5.16 Seegene Inc Company Overview
5.16.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Statens Serum Institut Company Overview
5.17.1 Statens Serum Institut Pipeline Products & Ongoing Clinical Trials Overview
5.18 University College London Company Overview
5.18.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of California San Francisco Company Overview
5.19.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Otago Company Overview
5.20.1 University of Otago Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Strathclyde Company Overview
5.21.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview

6 Mycobacterium Tuberculosis Tests- Recent Developments
6.1 Nov 18, 2020: HPE eHealth Centers provide free tuberculosis screening services to over 50,000 patients in India
6.2 Feb 19, 2020: QIAGEN’s QuantiFERON-TB Gold Plus to be adopted for latent TB testing in Nigeria
6.3 Jan 31, 2020: A novel in-vitro diagnostic test for drug-resistant tuberculosis and a personalized antibiotic treatment plan

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
Table 2: Mycobacterium Tuberculosis Tests - Pipeline Products by Segment
Table 3: Mycobacterium Tuberculosis Tests - Pipeline Products by Territory
Table 4: Mycobacterium Tuberculosis Tests - Pipeline Products by Regulatory Path
Table 5: Mycobacterium Tuberculosis Tests - Pipeline Products by Estimated Approval Date
Table 6: Mycobacterium Tuberculosis Tests Companies - Pipeline Products by Stage of Development
Table 7: Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
Table 8: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Reporter Phage Assay - Drug-Resistant Tuberculosis - Product Status
Table 10: Reporter Phage Assay - Drug-Resistant Tuberculosis - Product Description
Table 11: Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: PANDAA Assay - Tuberculosis - Product Status
Table 13: PANDAA Assay - Tuberculosis - Product Description
Table 14: Burnet Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Serological Diagnostic Test - Tuberculosis - Product Status
Table 16: Serological Diagnostic Test - Tuberculosis - Product Description
Table 17: Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Tr-DNA Tuberculosis Assay - Product Status
Table 19: Tr-DNA Tuberculosis Assay - Product Description
Table 20: Chronus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Antibody Based Diagnostic Assay - Tuberculosis - Product Status
Table 22: Antibody Based Diagnostic Assay - Tuberculosis - Product Description
Table 23: Diagnorite Innovative Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Diagnostic Kit - Tuberculosis - Product Status
Table 25: Diagnostic Kit - Tuberculosis - Product Description
Table 26: Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Diagnostic Test - Tuberculosis - Product Status
Table 28: Diagnostic Test - Tuberculosis - Product Description
Table 29: Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Diagnostic Tool - Malaria - Product Status
Table 31: Diagnostic Tool - Malaria - Product Description
Table 32: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: PZA Detection Kit - Product Status
Table 34: PZA Detection Kit - Product Description
Table 35: Omniome Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Mtb Drug Resistance DX - Product Status
Table 37: Mtb Drug Resistance DX - Product Description
Table 38: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Diagnostic Test - Tuberculosis - Product Status
Table 40: Diagnostic Test - Tuberculosis - Product Description
Table 41: Pulmonescence Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Fecal-Based Pediatric REFtb Assay - Product Status
Table 43: Fecal-Based Pediatric REFtb Assay - Product Description
Table 44: Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
Table 45: QuantiFERON - TB Access - Product Status
Table 46: QuantiFERON - TB Access - Product Description
Table 47: QuantiFERON-TB Gold Plus - LIAISON XL - Product Status
Table 48: QuantiFERON-TB Gold Plus - LIAISON XL - Product Description
Table 49: Rapid Diagnostic Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: MiniLab MDR-TB Assay - Product Status

List of Figures
Figure 1: Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
Figure 2: Mycobacterium Tuberculosis Tests - Pipeline Products by Segment
Figure 3: Mycobacterium Tuberculosis Tests - Pipeline Products by Territory
Figure 4: Mycobacterium Tuberculosis Tests - Pipeline Products by Regulatory Path
Figure 5: Mycobacterium Tuberculosis Tests - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 3
  • Albert Einstein College of Medicine
  • Aldatu Biosciences Inc
  • Burnet Institute
  • Cardiff Oncology Inc
  • Chronus Pharmaceuticals Inc
  • Diagnorite Innovative Healthcare Pvt Ltd
  • Emory University
  • Nagasaki University
  • Nipro Corp
  • Omniome Inc
  • OPKO Health Inc
  • Pulmonescence Diagnostics Inc
  • Qiagen NV
  • Rapid Diagnostic Pvt Ltd
  • Rutgers The State University of New Jersey
  • Seegene Inc
  • Statens Serum Institut
  • University College London
  • University of California San Francisco
  • University of Otago
  • University of Strathclyde
Note: Product cover images may vary from those shown
Adroll
adroll